KBC Group NV
- SEC CIK
- 0001411133
- Latest filing
- Aug 5, 2026
CTKB holding history
Cytek Biosciences, Inc. in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTKB overviewAll 13F holders of CTKBFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −3,884−100.0% | Sold out | Holders |
| Q1 2024 | 3,884 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,884 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,884 | $21.0K | <0.1% | −1,333−25.6% | Reduced | Holders |
| Q2 2023 | 5,217 | $45.0K | <0.1% | +5,217 | New | Holders |